For children, yes, the CDC’s “shared decision-making” guidance preserves the status quo in which Medicaid and U.S.

Moderna said mNEXSPIKE was approved by the FDA for use in adults aged 65 and up, as well as some individuals aged 12 to 64.

The US Centers for Disease Control and Prevention has updated its immunization schedule for children, days after US Health ...

"Political directives should not prevent individuals from seeking safe and effective care that they desire and deserve," ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

A new FDA framework for Covid-19 vaccines created confusion among physicians about what it means for young children ...

Health and Human Services Secretary Robert F. Kennedy Jr. on Tuesday announced the removal of the COVID-19 vaccine from the ...

A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

FDA officials outlined new restrictions for COVID-19 vaccines that could limit their use in the United States.

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

The US Food and Drug Administration is changing how it approves COVID-19 vaccines for Americans. What does that mean for ...

The Food and Drug Administration is taking a new approach to COVID-19 vaccines that would prioritize immunizations for people ...